Anna Vachulová, Ľuboš Urban, Hilda Bou Ezzeddine, Martin Svetlošák, Viliam Bernát, Michal Šašov, Peter Margitfalvi, Peter Hlivák
Atrial fibrillation is related to various symptomatology of patients. In the care of patients with atrial fibrillation pharmacological and non- pharmacological treatment options are always searched for. Pharmacological cardioversion is considered the most effective if initiated within 7 days after the onset of arrhythmia in which case restoration of sinus rhythm can be achieved in approximately 50-70 % of patients. The choice of an antiarrhythmic drug for cardioversion of atrial fibrillation depends on underlying heart disease. Atrial fibrillation is a major contributor to stroke and thromboembolism. The need of thromboproprophylaxis should be part of the management evaluation not only in pericardioversion period, but also in the long term management.